UNICREDIT BANK/CALL/FRESENIUS/30/1/17.12.25 Share Price

Warrant

DE000HD1ER65

Real-time BOERSE MUENCHEN 07:02:02 04/07/2024 BST
3.25 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/FRESENIUS/30/1/17.12.25
Current month+3.17%
1 month-21.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/07/24 3.25 0.00%
03/07/24 3.25 +1.56%
02/07/24 3.2 -2.44%
01/07/24 3.28 +4.13%
28/06/24 3.15 +0.96%

Real-time BOERSE MUENCHEN

Last update July 04, 2024 at 07:02 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HD1ER6
ISINDE000HD1ER65
Date issued 27/12/2023
Strike 30
Maturity 17/12/2025 (532 Days)
Parity 1 : 1
Emission price 4.73
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 5.05
Lowest since issue 2.15
Delta0.55x
Omega 4.788
Premium16.92x
Gearing8.69x
Moneyness 0.9487
Difference Strike 1.54
Difference Strike %+5.13%
Spread 0.09
Spread %2.71%
Theoretical value 3.275
Implied Volatility 24.57 %
Total Loss Probability 56.72 %
Intrinsic value 0.000000
Present value 3.275
Break even 33.28 €
Theta-0.03x
Vega0.14x
Rho0.18x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.46 EUR
Average target price
37.26 EUR
Spread / Average Target
+30.91%
Consensus